Compounds > staurosporine aglycone
Page last updated: 2024-10-29

staurosporine aglycone and Brain Injuries

staurosporine aglycone has been researched along with Brain Injuries in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, R1
Noble, E1
Tyagi, E1
Zhuang, Y1
Ying, Z1
Gomez-Pinilla, F1

Other Studies

1 other study available for staurosporine aglycone and Brain Injuries

ArticleYear
Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.
    Biochimica et biophysica acta, 2015, Volume: 1852, Issue:5

    Topics: Animals; Brain Injuries; Carbazoles; Cognition Disorders; Cyclic AMP Response Element-Binding Protei

2015